NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email A wellness machine with wings: Bombardier’s new Global 8000 isn’t quite a spa in the sky, but the Canadian manufacturer reckons its flagship business jet will give your health a boostRead More